Tech Times on MSN
Patient dies in BMS multiple sclerosis CAR T trial; company cannot link death to drug
CAR T therapy multiple sclerosis trial death: Bristol Myers Squibb disclosed the first fatality in its Phase 1 Breakfree-2 ...
By incorporating GaN power-conversion technology, LiTime has reduced the size of its new 12V lifepo₄ battery charger while ...
Pathos AI launches multi-year collaborations to build an AI-driven dataset for Alzheimer’s and other neurological diseases.
(NASDAQ: TEM, “Tempus”) today announced a multi-year agreement with Bristol Myers Squibb (NYSE: BMY, “BMS”), under which BMS ...
Pumitamig plus docetaxel demonstrated a confirmed objective response rate of 36.7% in patients with non-small cell lung ...
Adults and adolescents with eosinophilic esophagitis (EoE) treated once-monthly with the monoclonal antibody tezepelumab ...
Press Trust of India on MSN
BMS seeks PM's intervention for appointment of regular CMD of BSNL
New Delhi, Oct 7 (PTI) The Bharatiya Mazdoor Sangh (BMS) on Wednesday wrote to Prime Minister Narendra Modi seeking his "urgent" intervention for the appointment of a regular CMD of BSNL and an end to ...
Pumitamig plus docetaxel demonstrated encouraging responses in squamous and non-squamous non-small cell lung cancer across PD-L1 expression levels with a confirmed objective response rate of ...
BioNTech SE and Bristol Myers Squibb Company reported initial results from the global Phase 2 ROSETTA Lung-107 study of ...
Once an afterthought, air barriers are now essential in ensuring energy efficiency, moisture management, and occupant comfort ...
Battery Technology & Industry Insights. As global demand for alternative battery technologies continues to grow, sodium-ion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results